Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent.

Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE.

Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1246-52.

PMID:
17548692
[PubMed - indexed for MEDLINE]
Free Article
2.

Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).

Aziz MH, Kumar R, Ahmad N.

Int J Oncol. 2003 Jul;23(1):17-28. Review.

PMID:
12792772
[PubMed - indexed for MEDLINE]
3.

Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake.

Jannin B, Menzel M, Berlot JP, Delmas D, Lançon A, Latruffe N.

Biochem Pharmacol. 2004 Sep 15;68(6):1113-8. Review.

PMID:
15313407
[PubMed - indexed for MEDLINE]
4.

Resveratrol in human cancer chemoprevention--choosing the 'right' dose.

Scott E, Steward WP, Gescher AJ, Brown K.

Mol Nutr Food Res. 2012 Jan;56(1):7-13. doi: 10.1002/mnfr.201100400. Epub 2011 Oct 7. Review.

PMID:
22218912
[PubMed - indexed for MEDLINE]
5.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk